PAHC — PHIBRO ANIMAL HEALTH CORP
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1069899 ·
Last close
$34.92
Market Cap
$737.01M
52W High
$59.64
52W Low
$28.04
ADV30
212,053
Next earnings
2027-02-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 386,774,000 | 128,537,000 | 49,639,000 | 29,520,000 | 1,514,722,000 | 75,548,000 | 1,097,054,000 |
| Jun 2026 | 396,747,000 | 134,401,000 | 48,157,000 | 21,710,000 | 1,501,241,000 | 61,419,000 | 1,115,764,000 |
| Mar 2026 | 383,543,000 | 125,675,000 | 44,653,000 | 24,024,000 | 1,445,118,000 | 54,929,000 | 1,083,291,000 |
| Dec 2025 | 373,910,000 | 132,656,000 | 50,326,000 | 27,459,000 | 1,405,553,000 | 55,486,000 | 1,073,192,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$85,734,000
Investing CF
$-56,388,000
Financing CF
$-28,529,000
CapEx
$-64,064,000
Dividends Paid
$-19,471,000
Buybacks
—
EPS Diluted TTM
$2.51
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$377,606,000
Inventory
$567,139,000
Receivables
$221,710,000
ST Investments
$7,575,000
EBIT TTM
$183,553,000
Pretax Income TTM
$139,856,000
Interest Exp TTM
$43,697,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,540,973,952
EBITDA
$246,476,000
Free Cash Flow
$-4,774,875
Enterprise Value
$2,044,616,832
Total Cash
$87,114,000
Total Debt
$793,502,016
Shares Out
21,105,569
Trailing EPS
$2.51
Book Value
$10.29
ROE
28.2%
ROA
8.4%
Div Yield
1.46%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,518,093,000 | 194,396,000 | 99,720,000 | 1,501,241,000 | 1,115,764,000 | 385,477,000 | 68,954,000 |
| Jun 2025 | 1,296,215,000 | 110,465,000 | 48,264,000 | 1,360,900,000 | 1,075,218,000 | 285,682,000 | 80,124,000 |
| Jun 2024 | 1,017,679,000 | 53,315,000 | 2,416,000 | 982,184,000 | 725,543,000 | 256,641,000 | 87,594,000 |
| Jun 2023 | 977,889,000 | 71,847,000 | 32,606,000 | 971,397,000 | 688,888,000 | 282,509,000 | 13,310,000 |
TTM Snapshot
Revenues TTM
$1,518,093,000
NetIncome TTM
$99,720,000
OpCashFlow TTM
—
Assets (Latest)
$1,445,118,000
Forward EPS
$3.85
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $22.50 · spot: $35.57 · call volume: 66 · put volume: 21
Expected Move to 2026-12-18:
±$4.78
(13.42%) —
implied range
$30.79 –
$40.34
· ATM straddle on $35.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| APMD | Apnimed, Inc. | $741.03M | $17.80 | — |
| OBX | Obsidian Therapeutics, Inc. | $745.61M | $12.07 | — |
| IVEVF | Inventiva S.A. | $751.18M | $3.18 | — |
| IVA | Inventiva S.A. | $760.63M | $3.22 | — |
| SGMT | Sagimet Biosciences Inc. | $702.97M | $9.85 | — |
News headlines (Yahoo Finance, 1h cache)
Interpreting Phibro (PAHC) International Revenue Trends
2026-11-09 13:15 · Yahoo
Phibro: 3 Key Takeaways for Long-Term Investors
2026-11-09 12:43 · Yahoo
5 must-read analyst questions from Phibro Animal Health’s Q3 CY2026 earnings call
2026-11-08 20:29 · Yahoo
Phibro Animal (PAHC) Q1 2027 Earnings Call Transcript
2026-11-07 17:32 · Yahoo
Phibro Animal Health Corp (PAHC) (Q1 2027) Earnings Call Highlights: Solid Start to Fiscal 2027 ...
2026-11-07 01:11 · Yahoo
What Phibro Animal Health (PAHC) Said on Its Q1 Earnings Call
2026-11-05 22:14 · Yahoo
Phibro Animal Health Corporation Q1 2027 Earnings Call Summary
2026-11-05 13:30 · Yahoo
Phibro (PAHC) Reports Q1 Earnings: What Key Metrics Have to Say
2026-11-05 00:30 · Yahoo
Phibro: Fiscal Q1 Earnings Snapshot
2026-11-04 21:52 · Yahoo
Phibro Animal Health (NASDAQ:PAHC) exceeds Q3 CY2026 expectations
2026-11-04 21:34 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.